Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis
The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed...
Saved in:
Published in | Medicina cutánea ibero-latino-americana Vol. 7; no. 1-3; p. 1 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Portuguese |
Published |
Portugal
1979
|
Subjects | |
Online Access | Get full text |
ISSN | 0210-5187 |
Cover
Abstract | The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases. |
---|---|
AbstractList | The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases. The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases.The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with the drug and subsequently treated with 5-FC associated with other medicaments. All the associations, including that with amphotericin B, failed to overcome resistance. Experiments in mice and "in vitro" show a synergism between 5-FC and amphotericin B against "C. albicans", "C. neoformans" and "Fonsecaeae pedrosoi" already confirmed in human subjects infected with the above mentioned fungi. Resistance to 5-FC seems to be irreversible, as shown in previous experiments. The mechanism of action of the drugs on the fungi is discussed, as well as the fact that amphothericin B prevents the development of resistance to 5-FC. Results obtained with the use of the above association in 5 cases of chromomycosis are presented; all the patients had old and well established lesions, and in three cases these lesions were large and disseminated, conditions probably associated with the development of resistance to 5-FC used alone. The drugs were given in small doses, inferior to those usually recommended. The good therapeutic results seem to confirm the synergism observed in laboratory trials. Four cases were discharged as cured and one abandoned treatment for personal reasons. The association seems to act more rapidly than 5-FC alone. Tolerance was excellent in all cases. |
Author | Lopes, C F Alvarenga, R J Resende, M A Moreira, Y K |
Author_xml | – sequence: 1 givenname: C F surname: Lopes fullname: Lopes, C F – sequence: 2 givenname: M A surname: Resende fullname: Resende, M A – sequence: 3 givenname: R J surname: Alvarenga fullname: Alvarenga, R J – sequence: 4 givenname: Y K surname: Moreira fullname: Moreira, Y K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/398931$$D View this record in MEDLINE/PubMed |
BookMark | eNotkDtvwyAYRRnSR5L2H3Rg6mYJgzEwtlZfUqQu3i0CnxUqAy7gwf--qZLl3uWcO9wd2oQYYIO2hNak4rUU92iX8w8hLeOtukO3TEnF6i3qu-iPLujiYsBxxLwapyWmaNYSswuAdbBY-_kUCyRnXMCv-BzlBLgk0MVDKP-eOaXoo1_N2coP6GbUU4bHa-9R__7Wd5_V4fvjq3s5VDOndcUYCNGCbbVoqBgZM1YRzbkFS1kDVBJLuCCSNiCNIUKOepSWHI1kVIm6ZXv0fJmdU_xdIJfBu2xgmnSAuORBNEoJxdkZfLqCy9GDHebkvE7rcDmB_QEDM1mI |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Associação de 5-fluorocitosina e anfotericina B no tratamento da cromomicose |
ExternalDocumentID | 398931 |
Genre | English Abstract Journal Article |
GroupedDBID | 2WC 77H ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK E3Z EBS ECM EIF EJD FRP GROUPED_DOAJ GX1 NPM OK1 W2D Z7D 7X8 |
ID | FETCH-LOGICAL-p521-33e776ed6a7427f33cd90a55ded234e280d0570824e8cc078faf8d0bc83297163 |
ISSN | 0210-5187 |
IngestDate | Fri Jul 11 10:21:39 EDT 2025 Tue Aug 05 11:40:30 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-3 |
Language | Portuguese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p521-33e776ed6a7427f33cd90a55ded234e280d0570824e8cc078faf8d0bc83297163 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 398931 |
PQID | 74997953 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_74997953 pubmed_primary_398931 |
PublicationCentury | 1900 |
PublicationDate | 1979-00-00 19790101 |
PublicationDateYYYYMMDD | 1979-01-01 |
PublicationDate_xml | – year: 1979 text: 1979-00-00 |
PublicationDecade | 1970 |
PublicationPlace | Portugal |
PublicationPlace_xml | – name: Portugal |
PublicationTitle | Medicina cutánea ibero-latino-americana |
PublicationTitleAlternate | Med Cutan Ibero Lat Am |
PublicationYear | 1979 |
SSID | ssj0063569 |
Score | 1.2131661 |
Snippet | The authors discuss the problem of resistance of chromomycosis to 5-fluorocytosine (5-FC), observed in a previous study in 7 patients initially treated with... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1 |
SubjectTerms | Adult Aged Amphotericin B - administration & dosage Amphotericin B - pharmacology Amphotericin B - therapeutic use Capsules Chromobacterium - drug effects Chromoblastomycosis Cytosine - analogs & derivatives Drug Evaluation Drug Therapy, Combination Flucytosine - administration & dosage Flucytosine - pharmacology Flucytosine - therapeutic use Humans Injections, Intravenous Male Middle Aged |
Title | Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/398931 https://www.proquest.com/docview/74997953 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEF9EpPgiai31q-5D344tSXY3e3lU0Yr0-iBXuD4d2S8qaBI0J-hf70w2l0RRaPuyHHuXI8wvmY-d38wQ8lX7KNU6Ecz62DPh0jHTCt7HVKVgnoXxummkPfmZXvwSlzM564cgNtUltf5mnt6sK_kfVGEPcMUq2X9AtvtT2IDPgC-sgDCsf4UxvMwQ2HZOn2T-ZlGCRXqsS6Szh0asAFeJDZnNdTE6WdIae3450sr_ICfv9tHAVfdDb3USEu_5yCzqJqMeF1hYiRwThhy6omR5m_HptPuPsgqaZ0AaRnpfEfr7TvrD0-ObB6xECye7V31-aoLTQpvxR6Pf7SmsDXV6YSBMq7cgimQybu1oq2TV8FlifKAy46EiB_lWtw1aPANPKu6tVMcdDF-A0QXXCjl832cdpwd77TXxzvIO1sla-Pn78UPjR0w3yUYbANDjgOYWWanqbfKhlbT7SKYDUGnp6WtQKYBKh6DSEwoLgEo7UPG6F6DukOn52fT0grWjL1gF_hTj3CmVOpvmSiTKc25sFuVSWmcTLlwyjiz42eC9CTc2Brw8n_uxjbQB_Yw9wfgnslqUhftMaCqklkmkZc4dKGufOSuFyDTWIGuItnfJ0VIyc9AsmC7KC1cu7ucKgmGVSb5LdoLA5lVogDIPMt17Z3-frOMDEc6pDshqfbdwh-C51fpLg9YzFK5Iuw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+of+5-fluorocytosine+and+amphotericin+B+in+the+treatment+of+chromomycosis&rft.jtitle=Medicina+cut%C3%A1nea+ibero-latino-americana&rft.au=Lopes%2C+C+F&rft.au=Resende%2C+M+A&rft.au=Alvarenga%2C+R+J&rft.au=Moreira%2C+Y+K&rft.date=1979&rft.issn=0210-5187&rft.volume=7&rft.issue=1-3&rft.spage=1&rft_id=info%3Apmid%2F398931&rft.externalDocID=398931 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0210-5187&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0210-5187&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0210-5187&client=summon |